share_log

Lake Street Maintains Buy on Checkpoint Therapeutics, Lowers Price Target to $14

Lake Street Maintains Buy on Checkpoint Therapeutics, Lowers Price Target to $14

Lake Street 維持對 Checkpoint Therapeutics 的買入,將目標
Benzinga ·  2023/08/16 13:08

Lake Street analyst Thomas Flaten maintains Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and lowers the price target from $16 to $14.

Lake Street分析師托馬斯·弗拉滕維持Checkpoint Therapeutics(納斯達克股票代碼:CKPT)的買入,並將目標股價從16美元下調至14美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論